Barbara Katharina Geist

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Positron Emission Tomography

Benign Prostatic Hyperplasia

Virtual Reality

Top Venues

Scientific reports

Pharmaceuticals (Basel, Switzerland)

BMJ open diabetes research & care

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Sazan Rasul, Barbara Katharina Geist, Holger Einspieler, Harun Fajkovic, Shahrokh F Shariat, Stefan Schmitl, Markus Mitterhauser, Rainer Bartosch, Werner Langsteger, Pascal Andreas Thomas Baltzer, Thomas Beyer, Daria Ferrara, Alexander R Haug, Marcus Hacker, Ivo Rausch
Direct Patlak Reconstruction of [ 68 Ga]Ga-PSMA PET for the Evaluation of Primary Prostate Cancer Prior Total Prostatectomy: Results of a Pilot Study. International journal of molecular sciences 24 (18) (2023)
Barbara Katharina Geist, Roswitha Bammer-Zimmer
Effects of Early Toilet Training and Elimination Communication With Respect to Diaper Types. Clinical pediatrics (2023)
Chrysoula Vraka, Matej Murgaš, Lucas Rischka, Barbara Katharina Geist, Rupert Lanzenberger, Gregor Gryglewski, Thomas Zenz, Wolfgang Wadsak, Markus Mitterhauser, Marcus Hacker, Cécile Philippe, Verena Pichler
Simultaneous radiomethylation of [ 11 C]harmine and [ 11 C]DASB and kinetic modeling approach for serotonergic brain imaging in the same individual. Scientific reports 12 (1) (2022)
Eva-Maria Klebermass, Mahshid Mahmudi, Barbara Katharina Geist, Verena Pichler, Chrysoula Vraka, Theresa Balber, Anne Miller, Arvand Haschemi, Helmut Viernstein, Nataliya Rohr-Udilova, Marcus Hacker, Markus Mitterhauser
If It Works, Don't Touch It? A Cell-Based Approach to Studying 2-[18F]FDG Metabolism. Pharmaceuticals (Basel, Switzerland) 14 (9) (2021)
Sazan Rasul, Barbara Katharina Geist, Helmut Brath, Pascal Baltzer, Lalith Kumar Shiyam Sundar, Verena Pichler, Markus Mitterhauser, Alexandra Kautzky-Willer, Marcus Hacker
Response evaluation of SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus using 18F-FDG PET/MRI. BMJ open diabetes research & care 8 (1) (2021)